Loading clinical trials...
Loading clinical trials...
A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma
Conditions
Interventions
Bendamustine
Locations
25
Italy
SC Ematologia - AO SS. Antonio e Biagio e C. Arrigo
Alessandria, AL, Italy
SC Ematologia Spedali Civili
Brescia, BS, Italy
Divisione di Ematologia e Trapianti, Ospedale San Maurizio
Bolzano, BZ, Italy
Divisione di Ematologia, Centro Trapianto di Cellule Staminali
San Giovanni Rotondo, Foggia, Italy
Divisione Ematologia I , Ospedale San Martino
Genova, GE, Italy
S.C. Ematologia Azienda Ospedaliera Papardo
Messina, ME, Italy
Start Date
January 1, 2011
Primary Completion Date
March 1, 2012
Completion Date
May 1, 2015
Last Updated
October 13, 2017
NCT06667687
NCT05623982
NCT03314974
NCT04586478
NCT05054257
NCT01746849
Lead Sponsor
Fondazione Italiana Linfomi - ETS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions